Studies have demonstrated varying durability and levels of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after infection or vaccination. Effector functions are associated with four IgG subtypes (IgG1 – IgG4). In addition, two independent studies have reported elevated levels of IgG4 following the receipt of two or more mRNA vaccine doses, which is not observed with adenoviral vector vaccines